F240

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Hoegen-Saßmannshausen, P. (First author)DKFZ* ; Naumann, P. ; Hoffmeister-Wittmann, P. ; Ben Harrabi, S. ; Seidensaal, K. ; Weykamp, F.DKFZ* ; Mielke, T. ; Ellerbrock, M. ; Habermehl, D. ; Springfeld, C. ; Dill, M.DKFZ* ; Longerich, T. ; Schirmacher, P. ; Mehrabi, A. ; Chang, D.-H. ; Hörner-Rieber, J.DKFZ* ; Jäkel, O.DKFZ* ; Haberer, T. ; Combs, S. E.DKFZ* ; Debus, J.DKFZ* ; Herfarth, K. ; Liermann, J.
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial
JHEP reports 6(6), 101063 (2024) [10.1016/j.jhepr.2024.101063]2024     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Namoto, K. ; Baader, C. ; Orsini, V. ; et al
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo.
Cell stem cell 31(4), 554 - 569.e17 (2024) [10.1016/j.stem.2024.03.003]2024     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Olkus, A. ; Tomczak, A. ; Berger, A. K. ; Rauber, C. ; Puchas, P. ; Wehling, C. ; Longerich, T. ; Mehrabi, A. ; Chang, D.-H. ; Liermann, J. ; Schäfer, S. ; Pfeiffenberger, J. ; Jäger, D.DKFZ* ; Michl, P. ; Springfeld, C. ; Dill, M. (Last author)DKFZ*
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data.
Targeted oncology 19(2), 213-221 (2024) [10.1007/s11523-024-01044-1]2024     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Lapitz, A. ; Azkargorta, M. ; Milkiewicz, P. ; Olaizola, P. ; Zhuravleva, E. ; Grimsrud, M. M. ; Schramm, C. ; Arbelaiz, A. ; O'Rourke, C. J. ; La Casta, A. ; Milkiewicz, M. ; Pastor, T. ; Vesterhus, M. ; Jimenez-Agüero, R. ; Dill, M.DKFZ* ; Lamarca, A. ; Valle, J. W. ; Macias, R. I. R. ; Izquierdo-Sanchez, L. ; Castaño, Y. P. ; Caballero-Camino, F. J. ; Riaño, I. ; Krawczyk, M. ; Ibarra, C. ; Bustamante, J. ; Nova-Camacho, L. M. ; Falcon-Perez, J. M. ; Elortza, F. ; Perugorria, M. J. ; Andersen, J. B. ; Bujanda, L. ; Karlsen, T. H. ; Folseraas, T. ; Rodrigues, P. M. ; Banales, J. M.
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis and prognostication of cholangiocarcinoma.
Journal of hepatology 79(1), 93-108 (2023) [10.1016/j.jhep.2023.02.027]2023   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Tomczak, A. ; Springfeld, C. ; Dill, M. T.DKFZ* ; Chang, D.-H. ; Kazdal, D. ; Wagner, U. ; Mehrabi, A. ; Brockschmidt, A. ; Luedde, T. ; Naumann, P. ; Stenzinger, A. ; Schirmacher, P. ; Longerich, T.
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
British journal of cancer 127(9), 1701-1708 (2022) [10.1038/s41416-022-01932-1]2022   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Liu, C.-S. (First author)DKFZ* ; Rioja, I. ; Bakr, A. M. A.DKFZ* ; Veldwijk, M. R. ; Sperk, E. ; Herskind, C. ; Weichenhan, D.DKFZ* ; Prinjha, R. K. ; Plass, C.DKFZ* ; Schmezer, P.DKFZ* ; Popanda, O. (Last author)DKFZ*
Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation-induced pro-fibrotic fibroblast responses.
International journal of cancer 151(2), 275-286 (2022) [10.1002/ijc.33989]2022   BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS |